Ferose Iron Sucrose

Ferose Iron Sucrose1. Key BenefitsFerose Iron Sucrose is a mineral iron replacement product that replenishes body iron stores in patients with iron deficiency anemia, particularly those with chronic kidney disease (CKD). Iron is a mineral that the body needs to produce red blood cells, and when the body does not get enough iron, it cannot produce the number of normal red blood cells needed to maintain good health. The medication provides effective treatment for iron deficiency anemia with proven clinical outcomes and improved quality of life for patients.2. IndicationsFerose Iron Sucrose is indicated for:Treatment of iron-deficiency anemia in people with chronic kidney disease (CKD)Iron deficiency anemia in patients who cannot tolerate or do not respond to oral iron therapyIron replacement therapy in patients requiring rapid iron repletionPrevention of iron deficiency in high-risk populationsTreatment of iron deficiency anemia in hemodialysis and peritoneal dialysis patientsAnemia management in patients with chronic conditions affecting iron absorption3. How it WorksIron sucrose is an iron replacement compound that provides elemental iron to the body for red blood cell production. When administered intravenously, iron sucrose releases iron directly into the bloodstream, bypassing gastrointestinal absorption issues that may limit oral iron therapy effectiveness. The iron is then incorporated into hemoglobin synthesis and stored in body tissues, restoring normal iron levels and enabling adequate red blood cell production.4. Quality and SafetyManufacturing Standards: Ferose is manufactured by SPIMACO (Al Qassim Pharmaceutical Plant) using pharmaceutical-grade quality control processes ensuring consistent potency and safety.Safety Profile: Generally well-tolerated when administered according to recommended protocols. Hypersensitivity reactions, including anaphylactic shock, loss of consciousness, collapse, hypotension, dyspnea, and seizure may occur, requiring careful monitoring during administration.Clinical Monitoring: Monitor iron toxicity through periodic evaluation of laboratory parameters including transferrin saturation, serum ferritin, and complete blood counts to ensure appropriate dosing and prevent iron overload.5. Important ConsiderationsProduct Formulations:Ferose 20mg/ml Drops: Oral formulation for pediatric and adult useFerose Injectable: Intravenous iron sucrose solution for direct administrationFerose-F Tablets: Combined iron and folic acid formulation (100mg iron, 0.35mg folic acid)Ferose Syrup: 50mg/5ml oral liquid formulationDosing Considerations:Non-dialysis-dependent CKD: 200 mg IV injection for 5 doses over 14 days (cumulative 1000 mg)Peritoneal dialysis-dependent CKD: 300 mg IV infusion for 2 doses 14 days apart, then 400 mg IV infusion 14 days laterIndividual dosing based on patient weight, hemoglobin levels, and iron studiesContraindications:Known hypersensitivity to iron sucrose or any component of the formulationHistory of allergic reaction to iron injectionsIron overload conditionsAnemia not associated with iron deficiencyAdministration Guidelines:Intravenous administration should be performed in healthcare settings with emergency management capabilitiesAdminister as slow IV injection or diluted infusion per protocolMonitor patients for immediate and delayed hypersensitivity reactionsTest dose may be considered for high-risk patientsMonitoring Requirements:Complete blood count with differentialSerum iron, total iron-binding capacity, and transferrin saturationSerum ferritin levels to assess iron storesLiver function tests if indicatedVital signs during and after administrationSpecial Populations:Pregnancy: Use only if clearly needed; may harm unborn baby if severe reaction occurs during second or third trimesterLactation: Iron is excreted in breast milk; monitor nursing infantsElderly: May require dose adjustment based on renal functionPediatric: Safety and efficacy established in children ≥2 years oldProfessional Note: Ferose Iron Sucrose provides effective iron replacement therapy for patients with iron deficiency anemia, particularly those with chronic kidney disease. Healthcare providers must ensure proper patient selection, monitoring protocols, and emergency preparedness to maximize therapeutic benefits while minimizing risks.ReferencesIron Sucrose Injection – MedlinePlus Drug Information, National Library of MedicineVenofer (iron sucrose) Dosing and Clinical Guidelines – Medscape ReferenceIron Sucrose: Uses, Interactions, Mechanism of Action – DrugBank OnlineFerose Product Information – SPIMACO (Al Qassim Pharmaceutical Plant)Iron Sucrose Safety and Administration – Mayo Clinic Drug Information“Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia” – PMC Scientific Literature